Mitochondrial oxidative stress and mammalian healthspan

Mechanisms of Ageing and Development

Volumn 131, Issue 7-8, 2010, Pages 527-535

  Wanagat, Jonathan ^b   Dai, Dao Fu ^a   Rabinovitch, Peter ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antioxidants; Drug targeting; Healthspan; Mitochondria

Indexed keywords

10 (6' PLASTOQUINONYL)DECYLTRIPHENYLPHOSPHONIUM; ACETYLCYSTEINE; ANTIOXIDANT; CATALASE; DEXTRO ARGINYLDIMETHYLTYROSYLLYSYLPHENYLALANINE AMIDE; HYDROGEN PEROXIDE; MANGANESE SUPEROXIDE DISMUTASE; MITOQUINONE; PEROXIREDOXIN 3; PHENYLALANYL DEXTRO ARGINYLPHENYLALANYLLYSINE AMIDE; PHOSPHOLIPID HYDROPEROXIDE GLUTATHIONE PEROXIDASE; PLACEBO; PLASTOQUINONE; PROTEIN BAK; REACTIVE OXYGEN METABOLITE; THIOCTIC ACID; UBIDECARENONE; UNCLASSIFIED DRUG; ZIDOVUDINE;

AGING; ANTIOXIDANT ACTIVITY; ARTICLE; BLINDNESS; CALCIUM TRANSPORT; CARCINOGENESIS; CARDIOMYOPATHY; CLINICAL TRIAL; COCHLEA INJURY; ENZYME ACTIVITY; EXERCISE; EXPERIMENTAL ANIMAL; GENETIC MODEL; GLYCEMIC CONTROL; HEART INJURY; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEPATITIS C; HUMAN; KIDNEY INJURY; LIFESPAN; LIPID DIET; MITOCHONDRION; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PRESBYACUSIS; PRIORITY JOURNAL; RETINITIS PIGMENTOSA;

AGE FACTORS; AGING; ANIMALS; ANTIOXIDANTS; CELL AGING; HUMANS; LONGEVITY; MITOCHONDRIA; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

MAMMALIA;

EID: 77956185904     PISSN: 00476374     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mad.2010.06.002     Document Type: Article

References (57)

1. Adlam V.J., Harrison J.C., Porteous C.M., James A.M., Smith R.A., Murphy M.P., Sammut I.A. Targeting an antioxidant to mitochondria decreases cardiac ischemia-reperfusion injury. FASEB J. 2005, 19:1088-1095.
2. Agapova L.S., Chernyak B.V., Domnina L.V., Dugina V.B., Efimenko A.Y., Fetisova E.K., Ivanova O.Y., Kalinina N.I., Khromova N.V., Kopnin B.P., Kopnin P.B., Korotetskaya M.V., Lichinitser M.R., Lukashev A.L., Pletjushkina O.Y., Popova E.N., Skulachev M.V., Shagieva G.S., Stepanova E.V., Titova E.V., Tkachuk V.A., Vasiliev J.M., Skulachev V.P. Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 3. Inhibitory effect of SkQ1 on tumor development from p53-deficient cells. Biochemistry (Moscow) 2008, 73:1300-1316.
3. Anderson E.J., Lustig M.E., Boyle K.E., Woodlief T.L., Kane D.A., Lin C.T., Price J.W., Kang L., Rabinovitch P.S., Szeto H.H., Houmard J.A., Cortright R.N., Wasserman D.H., Neufer P.D. Mitochondrial H2O2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans. J. Clin. Invest. 2009.
4. Anisimov V.N., Bakeeva L.E., Egormin P.A., Filenko O.F., Isakova E.F., Manskikh V.N., Mikhelson V.M., Panteleeva A.A., Pasyukova E.G., Pilipenko D.I., Piskunova T.S., Popovich I.G., Roshchina N.V., Rybina O.Y., Saprunova V.B., Samoylova T.A., Semenchenko A.V., Skulachev M.V., Spivak I.M., Tsybul'ko E.A., Tyndyk M.L., Vyssokikh M.Y., Yurova M.N., Zabezhinsky M.A., Skulachev V.P. Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 5. SkQ1 prolongs lifespan and prevents development of traits of senescence. Biochemistry (Moscow) 2008, 73:1329-1342.
5. Antonenko Y.N., Avetisyan A.V., Bakeeva L.E., Chernyak B.V., Chertkov V.A., Domnina L.V., Ivanova O.Y., Izyumov D.S., Khailova L.S., Klishin S.S., Korshunova G.A., Lyamzaev K.G., Muntyan M.S., Nepryakhina O.K., Pashkovskaya A.A., Pletjushkina O.Y., Pustovidko A.V., Roginsky V.A., Rokitskaya T.I., Ruuge E.K., Saprunova V.B., Severina I.I., Simonyan R.A., Skulachev I.V., Skulachev M.V., Sumbatyan N.V., Sviryaeva I.V., Tashlitsky V.N., Vassiliev J.M., Vyssokikh M.Y., Yaguzhinsky L.S., Zamyatnin A.A., Skulachev V.P. Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 1. Cationic plastoquinone derivatives: synthesis and in vitro studies. Biochemistry (Moscow) 2008, 73:1273-1287.
6. Asin-Cayuela J., Manas A.R., James A.M., Smith R.A., Murphy M.P. Fine-tuning the hydrophobicity of a mitochondria-targeted antioxidant. FEBS Lett. 2004, 571:9-16.
7. Bakeeva L.E., Barskov I.V., Egorov M.V., Isaev N.K., Kapelko V.I., Kazachenko A.V., Kirpatovsky V.I., Kozlovsky S.V., Lakomkin V.L., Levina S.B., Pisarenko O.I., Plotnikov E.Y., Saprunova V.B., Serebryakova L.I., Skulachev M.V., Stelmashook E.V., Studneva I.M., Tskitishvili O.V., Vasilyeva A.K., Victorov I.V., Zorov D.B., Skulachev V.P. Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 2. Treatment of some ROS- and age-related diseases (heart arrhythmia, heart infarctions, kidney ischemia, and stroke). Biochemistry (Moscow) 2008, 73:1288-1299.
8. Butler R.N., Miller R.A., Perry D., Carnes B.A., Williams T.F., Cassel C., Brody J., Bernard M.A., Partridge L., Kirkwood T., Martin G.M., Olshansky S.J. New model of health promotion and disease prevention for the 21st century. BMJ 2008, 337:a399.
9. Chen L., Na R., Gu M., Salmon A.B., Liu Y., Liang H., Qi W., Van Remmen H., Richardson A., Ran Q. Reduction of mitochondrial H2O2 by overexpressing peroxiredoxin 3 improves glucose tolerance in mice. Aging Cell 2008, 7:866-878.
10. Cho J., Won K., Wu D., Soong Y., Liu S., Szeto H.H., Hong M.K. Potent mitochondria-targeted peptides reduce myocardial infarction in rats. Coron. Artery Dis. 2007, 18:215-220.
11. Cho S., Szeto H.H., Kim E., Kim H., Tolhurst A.T., Pinto J.T. A novel cell-permeable antioxidant peptide, SS31, attenuates ischemic brain injury by down-regulating CD36. J. Biol. Chem. 2007, 282:4634-4642.
12. Cocheme H.M., Kelso G.F., James A.M., Ross M.F., Trnka J., Mahendiran T., Asin-Cayuela J., Blaikie F.H., Manas A.R., Porteous C.M., Adlam V.J., Smith R.A., Murphy M.P. Mitochondrial targeting of quinones: therapeutic implications. Mitochondrion 2007, 7(Suppl.):S94-S102.
13. Dai D.F., Santana L.F., Vermulst M., Tomazela D.M., Emond M.J., MacCoss M.J., Gollahon K., Martin G.M., Loeb L.A., Ladiges W.C., Rabinovitch P.S. Overexpression of catalase targeted to mitochondria attenuates murine cardiac aging. Circulation 2009, 119:2789-2797.
14. Effros R.B., Fletcher C.V., Gebo K., Halter J.B., Hazzard W.R., Horne F.M., Huebner R.E., Janoff E.N., Justice A.C., Kuritzkes D., Nayfield S.G., Plaeger S.F., Schmader K.E., Ashworth J.R., Campanelli C., Clayton C.P., Rada B., Woolard N.F., High K.P. Aging and infectious diseases: workshop on HIV infection and aging: what is known and future research directions. Clin. Infect. Dis. 2008, 47:542-553.
15. Evans J.L., Goldfine I.D., Maddux B.A., Grodsky G.M. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr. Rev. 2002, 23:599-622.
16. Expert Panel on Detection E., Treatment of High Blood Cholesterol in Adults Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001, 285:2486-2497.
17. Filipovska A., Kelso G.F., Brown S.E., Beer S.M., Smith R.A., Murphy M.P. Synthesis and characterization of a triphenylphosphonium-conjugated peroxidase mimetic. Insights into the interaction of ebselen with mitochondria. J. Biol. Chem. 2005, 280:24113-24126.
18. Gane E., Orr D., Weilert F., Keogh G., Gibson M., Murphy M., Smith R., Lockhart M., Frampton C., Taylor K. Phase II study of the mitochondrial antioxidant mitoquinone for hepatitis C. 43rd Annual Meeting of the European Association for the Study of the Liver Journal of Hepatology 2008, S318.
19. Graham D., Huynh N.N., Hamilton C.A., Beattie E., Smith R.A., Cocheme H.M., Murphy M.P., Dominiczak A.F. Mitochondria-targeted antioxidant MitoQ10 improves endothelial function and attenuates cardiac hypertrophy. Hypertension 2009, 54:322-328.
20. Han Z., Varadharaj S., Giedt R.J., Zweier J.L., Szeto H.H., Alevriadou B.R. Mitochondria-derived reactive oxygen species mediate heme oxygenase-1 expression in sheared endothelial cells. J. Pharmacol. Exp. Ther. 2009, 329:94-101.
21. Herbst A., Pak J.W., McKenzie D., Bua E., Bassiouni M., Aiken J.M. Accumulation of mitochondrial DNA deletion mutations in aged muscle fibers: evidence for a causal role in muscle fiber loss. J. Gerontol. A: Biol. Sci. Med. Sci. 2007, 62:235-245.
22. Ho Y.S., Vincent R., Dey M.S., Slot J.W., Crapo J.D. Transgenic models for the study of lung antioxidant defense: enhanced manganese-containing superoxide dismutase activity gives partial protection to B6C3 hybrid mice exposed to hyperoxia. Am. J. Respir. Cell Mol. Biol. 1998, 18:538-547.
23. Hu D., Cao P., Thiels E., Chu C.T., Wu G.Y., Oury T.D., Klann E. Hippocampal long-term potentiation, memory, and longevity in mice that overexpress mitochondrial superoxide dismutase. Neurobiol. Learn. Mem. 2007, 87:372-384.
24. Ikeno Y., Bronson R.T., Hubbard G.B., Lee S., Bartke A. Delayed occurrence of fatal neoplastic diseases in ames dwarf mice: correlation to extended longevity. J. Gerontol. A: Biol. Sci. Med. Sci. 2003, 58:291-296.
25. Jang Y.C., Perez V.I., Song W., Lustgarten M.S., Salmon A.B., Mele J., Qi W., Liu Y., Liang H., Chaudhuri A., Ikeno Y., Epstein C.J., Van Remmen H., Richardson A. Overexpression of Mn superoxide dismutase does not increase life span in mice. J. Gerontol. A: Biol. Sci. Med. Sci. 2009, 64:1114-1125.
26. Jarvis R.M., Gottert J., Murphy M.P., Ledgerwood E.C. Mitochondria-targeted antioxidants do not prevent tumour necrosis factor-induced necrosis of L929 cells. Free Radic. Res. 2007, 41:1041-1046.
27. Jauslin M.L., Meier T., Smith R.A., Murphy M.P. Mitochondria-targeted antioxidants protect Friedreich Ataxia fibroblasts from endogenous oxidative stress more effectively than untargeted antioxidants. FASEB J. 2003, 17:1972-1974.
28. Kelso G.F., Porteous C.M., Coulter C.V., Hughes G., Porteous W.K., Ledgerwood E.C., Smith R.A., Murphy M.P. Selective targeting of a redox-active ubiquinone to mitochondria within cells: antioxidant and antiapoptotic properties. J. Biol. Chem. 2001, 276:4588-4596.
29. Kodell R.L., Blackwell B.N., Bucci T.J., Greenman D.L. Cause-of-death assignment at the National Center for Toxicological Research. Toxicol. Pathol. 1995, 23:241-247.
30. Kohler J.J., Cucoranu I., Fields E., Green E., He S., Hoying A., Russ R., Abuin A., Johnson D., Hosseini S.H., Raper C.M., Lewis W. Transgenic mitochondrial superoxide dismutase and mitochondrially targeted catalase prevent antiretroviral-induced oxidative stress and cardiomyopathy. Lab. Invest. 2009, 89:782-790.
31. Lamperth L., Dalakas M.C., Dagani F., Anderson J., Ferrari R. Abnormal skeletal and cardiac muscle mitochondria induced by zidovudine (AZT) in human muscle in vitro and in an animal model. Lab. Invest. 1991, 65:742-751.
32. Li D., Lai Y., Yue Y., Rabinovitch P.S., Hakim C., Duan D. Ectopic catalase expression in mitochondria by adeno-associated virus enhances exercise performance in mice. PLoS One 2009, 4:e6673.
33. Liang H., Van Remmen H., Frohlich V., Lechleiter J., Richardson A., Ran Q. Gpx4 protects mitochondrial ATP generation against oxidative damage. Biochem. Biophys. Res. Commun. 2007, 356:893-898.
34. Lippman S.M., Klein E.A., Goodman P.J., Lucia M.S., Thompson I.M., Ford L.G., Parnes H.L., Minasian L.M., Gaziano J.M., Hartline J.A., Parsons J.K., Bearden J.D., Crawford E.D., Goodman G.E., Claudio J., Winquist E., Cook E.D., Karp D.D., Walther P., Lieber M.M., Kristal A.R., Darke A.K., Arnold K.B., Ganz P.A., Santella R.M., Albanes D., Taylor P.R., Probstfield J.L., Jagpal T.J., Crowley J.J., Meyskens F.L., Baker L.H., Coltman C.A. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 2009, 301:39-51.
35. Magwere T., West M., Riyahi K., Murphy M.P., Smith R.A., Partridge L. The effects of exogenous antioxidants on lifespan and oxidative stress resistance in Drosophila melanogaster. Mech. Ageing Dev. 2006, 127:356-370.
36. Mizuguchi Y., Chen J., Seshan S.V., Poppas D.P., Szeto H.H., Felsen D. A novel cell-permeable antioxidant peptide decreases renal tubular apoptosis and damage in unilateral ureteral obstruction. Am. J. Physiol. Renal Physiol. 2008, 295:F1545-F1553.
37. Murphy M.P., Smith R.A. Targeting antioxidants to mitochondria by conjugation to lipophilic cations. Annu. Rev. Pharmacol. Toxicol. 2007, 47:629-656.
38. Neroev V.V., Archipova M.M., Bakeeva L.E., Fursova A., Grigorian E.N., Grishanova A.Y., Iomdina E.N., Ivashchenko Zh N., Katargina L.A., Khoroshilova-Maslova I.P., Kilina O.V., Kolosova N.G., Kopenkin E.P., Korshunov S.S., Kovaleva N.A., Novikova Y.P., Philippov P.P., Pilipenko D.I., Robustova O.V., Saprunova V.B., Senin I.I., Skulachev M.V., Sotnikova L.F., Stefanova N.A., Tikhomirova N.K., Tsapenko I.V., Shchipanova A.I., Zinovkin R.A., Skulachev V.P. Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 4. Age-related eye disease. SkQ1 returns vision to blind animals. Biochemistry (Moscow) 2008, 73:1317-1328.
39. Perez V.I., Bokov A., Van Remmen H., Mele J., Ran Q., Ikeno Y., Richardson A. Is the oxidative stress theory of aging dead?. Biochim. Biophys. Acta 2009, 1790:1005-1014.
40. Petri S., Kiaei M., Damiano M., Hiller A., Wille E., Manfredi G., Calingasan N.Y., Szeto H.H., Beal M.F. Cell-permeable peptide antioxidants as a novel therapeutic approach in a mouse model of amyotrophic lateral sclerosis. J. Neurochem. 2006, 98:1141-1148.
41. Rodriguez-Cuenca S., Cocheme H.M., Logan A., Abakumova I., Prime T.A., Rose C., Vidal-Puig A., Smith A.C., Rubinsztein D.C., Fearnley I.M., Jones B.A., Pope S., Heales S.J., Lam B.Y., Neogi S.G., McFarlane I., James A.M., Smith R.A., Murphy M.P. Consequences of long-term oral administration of the mitochondria-targeted antioxidant MitoQ to wild-type mice. Free Radic. Biol. Med. 2009.
42. Saretzki G., Murphy M.P., von Zglinicki T. MitoQ counteracts telomere shortening and elongates lifespan of fibroblasts under mild oxidative stress. Aging Cell 2003, 2:141-143.
43. Schriner S.E., Linford N.J., Martin G.M., Treuting P., Ogburn C.E., Emond M., Coskun P.E., Ladiges W., Wolf N., Van Remmen H., Wallace D.C., Rabinovitch P.S. Extension of murine life span by overexpression of catalase targeted to mitochondria. Science 2005, 308:1909-1911.
44. Skulachev V.P., Anisimov V.N., Antonenko Y.N., Bakeeva L.E., Chernyak B.V., Erichev V.P., Filenko O.F., Kalinina N.I., Kapelko V.I., Kolosova N.G., Kopnin B.P., Korshunova G.A., Lichinitser M.R., Obukhova L.A., Pasyukova E.G., Pisarenko O.I., Roginsky V.A., Ruuge E.K., Senin I.I., Severina I.I., Skulachev M.V., Spivak I.M., Tashlitsky V.N., Tkachuk V.A., Vyssokikh M.Y., Yaguzhinsky L.S., Zorov D.B. An attempt to prevent senescence: a mitochondrial approach. Biochim. Biophys. Acta 2009, 1787:437-461.
45. Snow B., Rolfe F., Murphy M., Smith R., Lockhart M., Frampton C., Taylor K. Phase II study of the mitochondrial antioxidant mitoquinone for Parkinson's disease. Neurology 2008, 70:A483-A484.
46. Song W., Shin J., Lee J., Kim H., Oh D., Edelberg J.M., Wong S.C., Szeto H., Hong M.K. A potent opiate agonist protects against myocardial stunning during myocardial ischemia and reperfusion in rats. Coron. Artery Dis. 2005, 16:407-410.
47. Supinski G.S., Murphy M.P., Callahan L.A. MitoQ administration prevents endotoxin-induced cardiac dysfunction. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2009, 297:R1095-R1102.
48. Szeto H.H. Development of mitochondria-targeted aromatic-cationic peptides for neurodegenerative diseases. Ann. N. Y. Acad. Sci. 2008, 1147:112-121.
49. Treuting P.M., Linford N.J., Knoblaugh S.E., Emond M.J., Morton J.F., Martin G.M., Rabinovitch P.S., Ladiges W.C. Reduction of age-associated pathology in old mice by overexpression of catalase in mitochondria. J. Gerontol. A: Biol. Sci. Med. Sci. 2008, 63:813-822.
50. Ursini F., Bindoli A. The role of selenium peroxidases in the protection against oxidative damage of membranes. Chem. Phys. Lipids 1987, 44:255-276.
51. Usui S., Komeima K., Lee S.Y., Jo Y.J., Ueno S., Rogers B.S., Wu Z., Shen J., Lu L., Oveson B.C., Rabinovitch P.S., Campochiaro P.A. Increased expression of catalase and superoxide dismutase 2 reduces cone cell death in retinitis pigmentosa. Mol. Ther. 2009, 17:778-786.
52. Wallace D.C. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu. Rev. Genet. 2005, 39:359-407.
53. Whiteman M., Spencer J.P., Szeto H.H., Armstrong J.S. Do mitochondriotropic antioxidants prevent chlorinative stress-induced mitochondrial and cellular injury?. Antioxid. Redox Signal. 2008, 10:641-650.
54. Yang L., Zhao K., Calingasan N.Y., Luo G., Szeto H.H., Beal M.F. Mitochondria targeted peptides protect against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity. Antioxid. Redox Signal. 2009, 11:2095-2104.
55. Zhao K., Luo G., Giannelli S., Szeto H.H. Mitochondria-targeted peptide prevents mitochondrial depolarization and apoptosis induced by tert-butyl hydroperoxide in neuronal cell lines. Biochem. Pharmacol. 2005, 70:1796-1806.
56. Zhao K., Luo G., Zhao G.M., Schiller P.W., Szeto H.H. Transcellular transport of a highly polar 3+ net charge opioid tetrapeptide. J. Pharmacol. Exp. Ther. 2003, 304:425-432.
57. Zhao K., Zhao G.M., Wu D., Soong Y., Birk A.V., Schiller P.W., Szeto H.H. Cell-permeable peptide antioxidants targeted to inner mitochondrial membrane inhibit mitochondrial swelling, oxidative cell death, and reperfusion injury. J. Biol. Chem. 2004, 279:34682-34690.